Table 1. Summary of included studies in the different defined groups.

Group	Total Number of Studies (%)	Patients per Study Median (IQR)
All patients	111	31 (19–46)
Group 1 (tumor resectable before treatment)	35 (31.5%)	32 (20–50)
Group 2 (tumor non-resectable before treatment)	57 (51.4%)	27 (18–38)
Group 3 (both or not defined)	19 (17.1%)	38 (24–82)